Target intelligence / Profile preview

Natural killer cell lectin-like receptor subfamily K member 1 (NKG2D) and its ligands (NKG2D/NKG2DL)

Target
NKG2D/NKG2DL
Molecular classification
Receptor, C-type lectin-like receptor, MHC class I-related protein
01

Overview

The Natural killer cell lectin-like receptor subfamily K member 1 (NKG2D) is a major activating receptor found on natural killer (NK) cells, CD8+ T cells, and gamma-delta T cells [1]. Its ligands, which include MICA, MICB, and the ULBP family, are stress-induced proteins that are typically absent from healthy cells but highly expressed on the surface of various cancers, including hepatocellular carcinoma (HCC) [2]. The interaction between NKG2D and its ligands serves as a critical danger signal that triggers the innate and adaptive immune systems to eliminate transformed cells [3]. In therapeutic contexts such as Vax-NK, autologous NK cells are expanded and activated ex vivo to enhance their NKG2D-mediated recognition of tumor cells [4]. Once infused, these cells bind to NKG2D ligands on HCC cells, inducing targeted cell death through the secretion of cytotoxic granules containing perforin and granzymes [5]. However, tumors often evade this response by shedding surface ligands into a soluble form, which acts as a decoy and downregulates NKG2D expression on immune cells [6]. Current research focuses on overcoming this evasion and optimizing the NKG2D-ligand axis for more effective cancer immunotherapy [7].

Other names
KLRK1CD314MHC class I polypeptide-related sequence A (MICA)MHC class I polypeptide-related sequence B (MICB)UL16-binding proteins (ULBPs)RAET1
02

Mechanism of action

Activation of NK cell cytotoxicity through the binding of the NKG2D receptor to stress-induced ligands (MICA/B, ULBPs) on the surface of tumor cells, leading to the release of perforin and granzymes.

03

Biological functions

Immune responseCell deathSignal transductionCytotoxicityImmune surveillance
04

Disease associations

CancerHepatocellular carcinomaAutoimmune diseaseInfection
05

Safety considerations

Tumor immune evasion via ligand shedding (sMICA/B)Potential off-target activation on stressed healthy tissuesLimited persistence of infused NK cellsDecoy effect of soluble ligands
06

Interacting drugs

Vax-NK

3 more in the full profile.

07

Biomarkers

Surface MICA/B expression on tumor cellsSoluble MICA (sMICA) serum levelsNKG2D expression on NK cellsULBP expression levels

Beyond the preview

Go deeper on Natural killer cell lectin-like receptor subfamily K member 1 (NKG2D) and its ligands (NKG2D/NKG2DL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural killer cell lectin-like receptor subfamily K member 1 (NKG2D) and its ligands (NKG2D/NKG2DL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call